H-1B sponsorship profile: Metaclipse Therapeutics Corporation. Across U.S. Department of Labor LCA disclosures, Metaclipse Therapeutics Corporation filed 1 Labor Condition Applications covering 1 H-1B worker positions between fiscal year 2025 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (1 certified of 1 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Metaclipse Therapeutics Corporation’s H-1B petitions range from $62,566 at the low end to $62,566 at the high end, with a petition-weighted average of $62,566. That range reflects the mix of occupations the company sponsors, led by Jr. Scientist (1 petitions at $62,566 avg). H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Metaclipse Therapeutics Corporation is headquartered in Atlanta, GA under NAICS code 54171, and places H-1B workers across 1 state, most heavily in GA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Metaclipse Therapeutics Corporation ranks. By H-1B petition volume, Metaclipse Therapeutics Corporation is #72,571 of 119,880 employers nationally and #2,427 of 3,758 employers headquartered in GA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.